Xenetic Biosciences, Inc. (XBIO) is a publicly traded Healthcare sector company. As of October 15, 2026, XBIO trades at $2.03 with a market cap of $4.92M and a P/E ratio of -1.89. XBIO moved +0.00% today. Year to date, XBIO is -2.33%; over the trailing twelve months it is -58.58%. Its 52-week range spans $1.87 to $13.93. Rallies surfaces XBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks XBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.03 |
| Market Cap | $4.92M |
| P/E Ratio | -1.89 |
| EPS | $-1.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.93 |
| 52-Week Low | $1.87 |
| Volume | 21.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.26M |
| Net Income | $-2.48M |
| Gross Margin | 0.00% |
XBIO analyst coverage data. Average price target: $0.00.